Growth Metrics

Quest Diagnostics (DGX) Operating Margin (2016 - 2026)

Quest Diagnostics' Operating Margin history spans 18 years, with the latest figure at 13.78% for Q1 2026.

  • On a quarterly basis, Operating Margin rose 74.0% to 13.78% in Q1 2026 year-over-year; TTM through Mar 2026 was 14.27%, a 56.0% increase, with the full-year FY2025 number at 14.1%, up 47.0% from a year prior.
  • Operating Margin hit 13.78% in Q1 2026 for Quest Diagnostics, roughly flat from 13.76% in the prior quarter.
  • Over the last five years, Operating Margin for DGX hit a ceiling of 19.65% in Q1 2022 and a floor of 5.79% in Q4 2022.
  • Historically, Operating Margin has averaged 13.9% across 5 years, with a median of 13.77% in 2024.
  • Biggest five-year swings in Operating Margin: tumbled -1375bps in 2022 and later soared 588bps in 2023.
  • Tracing DGX's Operating Margin over 5 years: stood at 5.79% in 2022, then soared by 102bps to 11.67% in 2023, then increased by 18bps to 13.77% in 2024, then fell by 0bps to 13.76% in 2025, then grew by 0bps to 13.78% in 2026.
  • Business Quant data shows Operating Margin for DGX at 13.78% in Q1 2026, 13.76% in Q4 2025, and 13.71% in Q3 2025.